How AI Is Already Reshaping Cancer Care

robot
Abstract generation in progress

Artificial intelligence (AI) is already significantly transforming cancer care, particularly in streamlining clinical trial processes and drug discovery. Pfizer, through experts like Jeanine Bortel and Tamara Mansfeld, is utilizing AI to identify eligible patients for trials more quickly, thereby broadening access to potentially life-changing treatments and accelerating breakthroughs in oncology research. This use of AI, including machine learning and large language models, is improving efficiency, precision, and the overall speed of developing new cancer therapies.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin